The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Neuropathic pain in the community: More under-treated than refractory?
Open accessAbstract
Best current estimates of neuropathic pain prevalence come from studies using screening tools detecting pain with probable neuropathic features; the proportion experiencing significant, long-term neuropathic pain, and the proportion not responding to standard treatment are unknown. These "refractory" cases are the most clinically important to detect, being the most severe, requiring specialist treatment. The aim of this study was to estimate the proportion of neuropathic pain in the population that is "refractory," and to quantify associated clinical and demographic features. We posted self-administered questionnaires to 10,000 adult patients randomly selected from 10 general practitioner practices in 5 UK locations. The questionnaire contained chronic pain identification and severity questions, cause of pain, SF-12, EQ-5D, S-LANSS (Self-administered Leeds Assessment of Neuropathic Signs and Symptoms), PSEQ (Pain Self-Efficacy Questionnaire), use of neuropathic pain medications, and health care utilisation. These data were combined to determine the presence and characteristics of "refractory" neuropathic pain according to the defining features identified by a Delphi survey of international experts. Graded categories of chronic pain with and without neuropathic characteristics were generated, incorporating the refractory criteria. Completed questionnaires were returned by 4451 individuals (response rate 47%); 399 had "chronic pain with neuropathic characteristics" (S-LANSS positive, 8.9% of the study sample); 215 (53.9%) also reported a positive relevant history ("Possible neuropathic pain"); and 98 (4.5% of all Chronic Pain) also reported an "adequate" trial of at least one neuropathic pain drug ("Treated possible neuropathic pain"). The most refractory cases were associated with dramatically poorer physical and mental health, lower pain self-efficacy, higher pain intensity and pain-related disability, and greater health care service use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Epidemiological surveys have shown that many patients with neuropathic pain do not receive appropriate treatment for their pain.2,6,7”
From Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis (2015) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WARE, J. E., KOSINSKI, M., & KELLER, S. D. (1996) · Medical Care · doi:10.1097/00005650-199603000-00003 · Cited by 17,392
EuroQol: a new facility for the measurement of health-related quality of life
(1990) · Health Policy · doi:10.1016/0168-8510(90)90421-9 · Cited by 15,736
Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment
Breivik, H., Collett, B., Ventafridda, V., Cohen, R., & Gallacher, D. (2006) · European Journal of Pain · doi:10.1016/j.ejpain.2005.06.009 · Cited by 5,486
Grading the severity of chronic pain
Von Korff, M., Ormel, J., Keefe, F. J., & Dworkin, S. F. (1992) · Pain · doi:10.1016/0304-3959(92)90154-4 · Cited by 3,022
Classification of chronic pain
Merskey, H. (1994) · Medical Entomology and Zoology · Cited by 2,952
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Participation Rates in Epidemiologic Studies
Galea, S., & Tracy, M. (2007) · Annals of Epidemiology · doi:10.1016/j.annepidem.2007.03.013 · Cited by 1,877
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri‐Minet, M., Attal, N., Laurent, B., & Touboul, C. (2007) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,827
The pain self-efficacy questionnaire: Taking pain into account
Nicholas, M. K. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2005.12.008 · Cited by 1,656
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–188 of 188
Jo, H.-G., & Lee, D. (2021) · Pharmaceuticals · doi:10.3390/ph14111202 · Cited by 10
Mistry, J., Falla, D., Noblet, T., Heneghan, N. R., & Rushton, A. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-033547 · Cited by 9
Määttä, J., Martikainen, A., Ikäheimo, T.-M., Nissen, M., Viinamäki, H. T., zu Fraunberg, M. V. U., & Huttunen, J. (2019) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.13045 · Cited by 9
P2X receptors and trigeminal neuralgia
Li, J.-J., Liu, Z.-X., Zhang, Y., & Xue, G.-Y. (2019) · Neuroreport · doi:10.1097/wnr.0000000000001266 · Cited by 9
Boulton, A. J. M., Jensen, T. S., Luecke, T. D., Petersen, E., Pop‐Busui, R., Taylor, R. S., Tesfaye, S. H., Vileikytė, L., & Ziegler, D. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110763 · Cited by 8
de la Calle, J. L., Andrés, J. A. D., Pérez, M., & López, V. (2014) · Clinical Drug Investigation · doi:10.1007/s40261-014-0239-5 · Cited by 8
Somatoforme Störungen – somatoforme Belastungsstörung und verwandte Störungen
Kapfhammer, H. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_74 · Cited by 8
Mendes, S. M. D., Sá, K. N., Meneses, F. M., de Andrade, D. C., & Baptista, A. F. (2020) · Psychology Health & Medicine · doi:10.1080/13548506.2020.1749677 · Cited by 8
Plasma and cerebrospinal fluid pharmacokinetics of ondansetron in humans
Chiang, M., Frey, K., Lee, C., Kharasch, E. D., Tallchief, D., Sawyer, C., Blood, J., Back, H., Kagan, L., & Haroutounian, S. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14412 · Cited by 8
EEG neurofeedback for the treatment of neuropathic pain in the elderly—a mechanistic review
Chmiel, J., Kopańska, M., Leszek, J., Trojniak, J., & Ros, T. (2025) · GeroScience · doi:10.1007/s11357-025-01848-7 · Cited by 7
Multimodal Approaches in the Treatment of Chronic Peripheral Neuropathy—Evidence from Germany
Romeyke, T., & Stummer, H. (2024) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph21010066 · Cited by 45
Carvajal, A. M. R., Osorio, C. A. O., Rojas, S. M., & Ibatá, L. (2018) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2018.3673/2018 · Cited by 7
A systematic review of experimental methods to manipulate secondary hyperalgesia in humans: protocol
Madden, V. J., Bedwell, G. J., Chikezie, P. C., Rice, A. S. C., & Kamerman, P. R. (2019) · Systematic Reviews · doi:10.1186/s13643-019-1120-7 · Cited by 7
Moura-Pacheco, T. L., Martins-Pereira, R. C., de Medeiros, P. S., Sbragia, L., Leite‐Panissi, C. R. A., Machado, H. R., Coimbra, N. C., & de Freitas, R. L. (2023) · Experimental Brain Research · doi:10.1007/s00221-023-06657-y · Cited by 6
Maiga, Y. M., Sangho, O., Konipo, F. D. N., Diallo, S. H., Coulibaly, S. D. P., Sangaré, M., Péréon, Y., Giumelli, B., Sanou, M., Coulibaly, A., et al. (2021) · eNeurologicalSci · doi:10.1016/j.ensci.2021.100312 · Cited by 5
Tacrine alleviates neuropathic pain in mice by mimicking the cell adhesion molecule L1
(2021) · Signa Vitae · doi:10.22514/sv.2021.081 · Cited by 6
How do people understand their neuropathic pain? A Q-study
Martin, S., Daniel, C., & Williams, A. C. D. C. (2013) · Pain · doi:10.1016/j.pain.2013.10.021 · Cited by 6
Locomotor therapy with extended-release crystalline glucocorticoids
Badokin, V. V. (2013) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2013-2420 · Cited by 6
Monteiro, C. E. D. S. (2015) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000282 · Cited by 5
Sameera, Shah, F. A., & Rashid, S. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.027 · Cited by 6
Kansal, A., Copley, S., Duarte, R. V., Warren, F. C., Taylor, R. S., & Eldabe, S. S. (2025) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2025.04.004 · Cited by 5
Lara-Almúnia, M., Moreno, N. E. M., Torres, C. V., Sárraga, J. G., & Álvarez, R. M. (2024) · World Neurosurgery · doi:10.1016/j.wneu.2024.11.028 · Cited by 5
Afonso, A. S., Gálvez, R., Paremés, E., Navarro, A. M., Ochoa, D., & Pérez, C. (2022) · Pain Practice · doi:10.1111/papr.13176 · Cited by 5
Prediction of therapeutic response to pregabalin in subjects with neuropathic pain
Almas, M., Parsons, B., & Whalen, E. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1520694 · Cited by 5
Evaluación del dolor en consultas de reumatología españolas: Estudio EVADOR
Plana-Veret, C., Seoane‐Mato, D., Goicoechea, C., & Fuentes, J. V. (2019) · Reumatología Clínica · doi:10.1016/j.reuma.2019.01.006 · Cited by 5
Assis, D. V., Campos, A. C., Paschoa, A. F. N., Santos, T. F., Fonoff, E., & Pagano, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097796 · Cited by 5
Shahid, M., Subhan, F., Ahmad, N., Din, Z. U., Ullah, I., Rahman, S. U., Ullah, R., Farooq, U., Alam, J., Nawaz, N. U. A., et al. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150217 · Cited by 4
Moisset, X., Pagé, M. G., Pereira, B., & Choinière, M. (2025) · European Journal of Pain · doi:10.1002/ejp.70137 · Cited by 4
Zhou, P., Lü, L., Cao, Y. Q., Chen, J., Chen, C., Zhang, X., Chen, J., Deng, Y., Lin, Z., Lai, Y., et al. (2025) · Molecular Medicine Reports · doi:10.3892/mmr.2025.13717 · Cited by 4
Stellenwert der Rückenmarkstimulation bei schmerzhafter diabetischer Polyneuropathie
Ziegler, D., Luecke, T. D., Ahmadi, R., Maciaczyk, J., Siegel, E. G., Sommer, C., & Rasche, D. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2542-0518 · Cited by 4
Design, synthesis, and biological activity of new endomorphin analogs with multi-site modifications
Zhao, L., Luo, K., Wang, Z., Wang, Y., Zhang, X., Yang, D., Ma, M., Zhou, J., Cui, J., Wang, J., et al. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115438 · Cited by 4
Spinal cord stimulation in the treatment of chronic pain
Isagulyan, E. D., Slavin, K. V., Tomskiy, A. A., Asriyants, S., Makashova, E., Дорохов, Е. В., & Isagulyan, D. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2020120081160 · Cited by 4
Montigne, E., & Balayssac, D. (2023) · Pharmaceuticals · doi:10.3390/ph16101363 · Cited by 4
Treatment of Peripheral Nerves With Pulsed Radiofrequency: A Retrospective Analysis
Haehnsen, A., Mauermann, E., & Kalimeris, K. (2025) · Cureus · doi:10.7759/cureus.79879 · Cited by 3
Shen, W., Song, S., Zhao, X., Li, D., Liu, J., & Yue, S. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152263 · Cited by 3
A Retrospective Analysis of Pain Etiology in Middle-Aged Patients with Peripheral Neuropathy
Szewczyk, A. K., Jamróz-Wiśniewska, A., & Rejdak, K. (2021) · Medicina · doi:10.3390/medicina57080787 · Cited by 4
Naumov, A. V., Vorobieva, N. M., Khovasova, N. O., Ткачева, О. Н., Kotovskaya, Y. V., Selezneva, E. V., & Ovcharova, L. N. (2022) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2022-3-50-59 · Cited by 3
Treating Chronic Nonmalignant Pain
Snell, S., Hughes, T., Fore, C., Lukman, R., & Morgan, B. T. (2018) · Journal of Christian Nursing · doi:10.1097/cnj.0000000000000569 · Cited by 3
Pain assessment in Spanish rheumatology outpatient clinics: EVADOR study
Plana-Veret, C., Seoane‐Mato, D., Goicoechea, C., & Fuentes, J. V. (2020) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2019.01.003 · Cited by 3
Churyukanov, M. V., & Дорохов, Е. В. (2013) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2013-2419 · Cited by 3
Transcranial magnetic stimulation as a new tool to control pain perception
Onesti, E., Gori, M. C., Frasca, V., & Inghilleri, M. (2016) · World Journal of Anesthesiology · doi:10.5313/wja.v5.i1.15 · Cited by 3
Genç, D., Zibandeh, N., Yıldız, Y. A., Aslan, S., Demirtaş, F., Karaöz, E., & Akkoç, T. (2017) · Journal of Pain & Relief · doi:10.4172/2167-0846.1000302 · Cited by 3
Tsai, J.-K., Wu, Z., Yang, S., Huang, S., Chen, H.-L., Teng, W.-N., Su, F.-W., Chen, W.-F., Wen, Z., & Sung, C. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106013 · Cited by 2
Roche, J. C. (2020) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2020.3727/2019 · Cited by 2
Correlates of chronic pain onset and recovery in the CoLaus cohort
Dirupo, G., Rossel, J., Fournier, N., D'Andrea, A., Vollenweider, P., Décosterd, I., Suter, M. R., & Berna, C. (2024) · European Journal of Pain · doi:10.1002/ejp.4712 · Cited by 2
Epigenetic Regulation of Peripheral Macrophages in Neuropathic Pain
Kiguchi, N., Matsuzaki, S., Saika, F., Kobayashi, D., & Kishioka, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814070-3.00002-8 · Cited by 1
Szewczyk, A. K., Jamróz-Wiśniewska, A., Gonet, K. E., & Rejdak, K. (2024) · Neurologia i Neurochirurgia Polska · doi:10.5603/pjnns.96769 · Cited by 1
Fitzrol, D. N., Sitthinamsuwan, B., Jirachaipitak, S., Euasobhon, P., Zinboonyahgoon, N., & Nunta-aree, S. (2026) · Neurosurgical Review · doi:10.1007/s10143-025-03950-y · Cited by 1
Sivasankari, V., Dr.E.Manivannan, M. D., & Dr.S.P.PRIYADARSINI, M. D. (2017) · International Journal of Basic & Clinical Pharmacology · doi:10.18203/2319-2003.ijbcp20175210 · Cited by 1
Opstacles in neuropathic pain treatment in the developing country: Neuropathic pain treatment
Jovičić, J., Volaš, L., Brkić, T., Terzić, B., Garić, A., Gvozdić, B., & Antonijević, V. (2018) · Serbian Journal of Anesthesia and Intensive Therapy · doi:10.5937/sjait1804103j · Cited by 1
Dolor neuropático: un reto constante
Fuentes, J. V. (2021) · Revista de la Sociedad Española del Dolor · doi:10.20986/resed.2021.3938/2021 · Cited by 1
Oral administration of East Asian herbal medicine for peripheral neuropathy
Lee, H., Jo, H.-G., & Lee, D. (2021) · Medicine · doi:10.1097/md.0000000000027644 · Cited by 1
Muñetón, C. L., Bedoya, S. P. B., Ángel, I., Vásquez-Montoya, M. G., Toro, S. G., & Vallejo, D. (2024) · Revista de Investigación e Innovación en Ciencias de la Salud · doi:10.46634/riics.274 · Cited by 1
Peripheral Sensitization: Peripheral Mechanisms of Neuroma and Neuropathic Pain
Scott, B. B., & Winograd, J. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-59758-9_2 · Cited by 1
dos Santos, B. C., Reis, A. K. G., Nucci, R. A. B., Campos, A. C. P., Martins, D. O., Daldegan‐Bueno, D., & Pagano, R. L. (2024) · Brain Behavior and Immunity Integrative · doi:10.1016/j.bbii.2024.100087 · Cited by 1
Meng, J., Zhang, Z., Wang, Y., Long, L., Luo, A., Luo, Z., Cai, K., Chen, X., & Nie, H. (2024) · Purinergic Signalling · doi:10.1007/s11302-024-10056-5 · Cited by 1
Neuropathic Pain: Mechanisms, Clinical Aspects and Treatment Options
Kersebaum, D., Sachau, J., Fabig, S., & Baron, R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.24257-0 · Cited by 1
Somatoforme Störungen – somatoforme Belastungsstörung und verwandte Störungen
Kapfhammer, H. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_74-1 · Cited by 2
Kamerman, P. R., Hoosen, T., Mnguni, N., & Chikezie, P. C. (2026) · medRxiv · doi:10.64898/2026.01.14.26344090 · Cited by 1
Influence du DN4 dans la prise en charge de la douleur en médecine générale
Rambaud, C. (2013) · HAL
da Silva, A. C. S. M. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Chesi, G., Scanelli, G., Gilioli, F., Scalabrini, E., Giumelli, C., & Franco, F. (2015) · Italian Journal of Medicine · doi:10.4081/itjm.2015.441
Ask the Experts: Neuropathic Pain from a Primary Care Perspective
Smith, B. H. (2013) · Pain Management · doi:10.2217/pmt.13.6
Self-citationPharmacotherapyofneuropathicpain:whichdrugs, which treatment algorithms?
Attal, N., & Bouhassira, D. (2015)
Kuo, K.-L. (2019) · J. Willard Marriott Library · doi:10.26053/0j-90a4-pspw
DIAGNOSES AND APPROACHES TO PATIENTS WITH NEUROTIC PAIN
Starchina, Y. A. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-10-69-72
Acute Anti-Allodynic Actions of Gabapentin
Alles, S. R. A. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3x63bb02
Application of Herpes Simplex Virus Vectors in Treatment of Neuropathic Pain
Hao, S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809813-4.00018-1
Neuropathic Pain in Nervous System Tumours
Caraceni, A. T., & Formaglio, F. (2019) · Springer eBooks · doi:10.1007/978-3-319-95684-8_12
Interventional pain treatment – overview of available procedures
But, M., Król, A., Goroszeniuk, T., Góraj, E., Starczewski, K., Hura, G., Ługin, R. D., Kotfis, K., & Rykowski, J. (2019) · Ból · doi:10.5604/01.3001.0013.1573
Dor neuropática – investigação e tratamento específico
Kubota, G. T., & de Andrade, D. C. (2021) · Revista Paulista de Reumatologia · doi:10.46833/reumatologiasp.2021.20.2.17-27
Targeted Muscle Reinnervation: Does it have a place within the National Health Service (NHS)?
Bawa, J., & Gnanarajah, S. (2021) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2021.08.029
Start low, aim high. The role of doses in successful pregabalin therapy
Woroń, J. (2022) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2022.001
Mshelia, C., Kennedy, M., & McHugh, G. A. (2023) · Health Open Research · doi:10.12688/healthopenres.13153.1
Pang, J., Zhao, Y., Hu, Z., Xu, Y., Liu, X., Hu, Y., & Wu, W. (2023) · Research Square · doi:10.21203/rs.3.rs-3649254/v1
Clinical Profile of Non-traumatic Acute Abdominal Pain Presenting to Emergency Department
Amal, S., Salim, A., Salim, D., Mohanan, P., Sankar, H. H., Davis, A. D., Christo, A. J., Anju, S. S., Purackel, A., & Balan, A. S. (2025) · National Journal of Emergency Medicine SEMI · doi:10.5005/njem-11015-0068
The Normalcy Paradox: When Well-Intentioned Reassurance Suppresses TreatmentPreprint
Lawal, S., Chew, B., & Amir, O. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5383396
Analgesic and anti-inflammatory properties of carbenoxolone: a review
Ahmadpourmir, H., Tabar, H. M., Gholamnezhad, Z., Ghorani, V., Taghizadeh, S. F., Tsarouhas, K., Hashemzaei, M., & Rezaee, R. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01937-1 · Cited by 2
Giovannico, G., Pellicciari, L., Cacciola, F., Bianco, A., Rinaldi, D., Laricchiuta, P., Giannotta, G., & Angilecchia, D. (2026) · Disability and Rehabilitation · doi:10.1080/09638288.2026.2672855
Reply to the letter: “Is the experience of chronic pain different in frail older adults?”
Cirino, N. T. D. O., de Aquino, M. P. M., Lima, C. A., Santos, F. C., Ventura, M. D. M., & Perracini, M. R. (2026) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0046-1822634
Moisset, X. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.2148
Altun, G., Esin, A., Özşahin, Y., Arslan, Ş., Balcioglu, S., Sandal, B., Erkalp, K., & Salihoğlu, Z. (2026) · BMC Anesthesiology · doi:10.1186/s12871-026-04138-7
Reassurance through normalization inadvertently suppresses treatment
Lawal, S., Chew, B., & Amir, O. (2026) · Nature Human Behaviour · doi:10.1038/s41562-026-02542-0
Eerdekens, M., Both, C., & Freitas, R. L. (2026) · Pain and Therapy · doi:10.1007/s40122-026-00884-1
Dronabinol for Neuropathic Pain in Palliative Care
Boogaerts, G., Rego, A., FREEMAN, H., Baumrucker, S. J., & Rashid, S. (2026) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2026.2718824
Metadata
- Authors
- Torrance, N., Ferguson, J. A., Afolabi, E., Bennett, M. I., Serpell, M. G., Dunn, K. M., & Smith, B. H.
- Affiliations
- University of Leeds (GB)
- University of Dundee (GB)
- University of Aberdeen (GB)
- University of Glasgow (GB)
- Keele University (GB)
- Corresponding author
- Torrance, Nicola
- Venue
- Pain
- Published
- 2013-05
- Volume
- 154
- Issue
- 5
- Pages
- 690-699
- ISSN
- 0304-3959 (ISSN-L)
- PMC
- PMC3630326
- OpenAlex
- W2026664444
- Cited by
- 188
- References
- 48
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 12 · 2023: 9 · 2022: 7 · 2021: 20 · 2020: 19 · 2019: 13 · 2018: 19 · 2017: 22 · 2016: 12 · 2015: 12 · 2014: 9 · 2013: 12
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- Locations
- Pain (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- Funders
- Pfizer UK Ltd. Kate Dunn is supported by the Wellcome Trust (083572)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Health Sciences › Health Professions › Physical Therapy, Sports Therapy and Rehabilitation › Musculoskeletal pain and rehabilitation
- Keywords
- neuropathic pain, refractory neuropathic pain, undertreatment, prevalence, chronic pain, pain self-efficacy, pain-related disability, health care utilization, physical and mental health, neuropathic pain medications, community-dwelling adults, general practice
- MeSH terms
- Adolescent, Adult, Aged, Analgesics, Data Interpretation, Statistical, Drug Resistance, Humans, Male, Middle Aged, Neuralgia, Pain Measurement, Quality of Life, Surveys and Questionnaires, Socioeconomic Factors, Prevalence, Treatment Outcome, Self Efficacy, Young Adult, Chronic Pain
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
